Evaluating Laser Photobiomodulation for the Treatment of Neuropathic Pain in Chemotherapy-induced Peripheral Neuropathy: a Randomized, Non-comparative, Placebo-controlled, Single-blinded, Phase II Clinical Trial in Cancer Patients
Evaluating Laser Photobiomodulation for the Treatment of Neuropathic Pain in Chemotherapy-induced Peripheral Neuropathy: a Randomized, Non-comparative, Placebo-controlled, Single-blinded, Phase II Clinical Trial in Cancer Patients is a NA clinical asset sponsored by Institut du Cancer de Montpellier - Val d'Aurelle in Cancer Survivors, Peripheral Neuropathic Pain. SEO and diligence focus: Photobiomodulation sessions, endpoint relevance, enrollment feasibility, competitive positioning, readout timing and IP durability.
Indication: Cancer Survivors
Modality: medical device
Target: Photobiomodulation sessions
Sponsor: Institut du Cancer de Montpellier - Val d'Aurelle
Source URL: ClinicalTrials.gov
Source updated: Detailed source ingestion pending
Ingested: Jul 22, 2026
Model: trialsignal-ai-v1
Validation: validated
Matched by target_normalized: Photobiomodulation sessions
View original source fields
Condition raw: Cancer Survivors, Peripheral Neuropathic Pain
Condition normalized: Cancer Survivors, Peripheral Neuropathic Pain
Modality raw: medical device
Modality normalized: medical device
Target raw: Photobiomodulation sessions
Target normalized: Photobiomodulation sessions